Your browser doesn't support javascript.
loading
Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab.
Frerichs, Kristine A; Broekmans, Marloes E C; Marin Soto, Jhon A; van Kessel, Berris; Heymans, Martijn W; Holthof, Lisa C; Verkleij, Christie P M; Boominathan, Rengasamy; Vaidya, Bhavesh; Sendecki, Jocelyn; Axel, Amy; Gaudet, Francois; Pillarisetti, Kodandaram; Zweegman, Sonja; Adams, Homer C; Mutis, Tuna; van de Donk, Niels W C J.
Afiliação
  • Frerichs KA; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Broekmans MEC; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Marin Soto JA; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • van Kessel B; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Heymans MW; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Biostatistics, Amsterdam, the Netherlands.
  • Holthof LC; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Verkleij CPM; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Boominathan R; Janssen Research and Development, LLC, Spring House, Pennsylvania.
  • Vaidya B; Janssen Research and Development, LLC, Spring House, Pennsylvania.
  • Sendecki J; Janssen Research and Development, LLC, Spring House, Pennsylvania.
  • Axel A; Janssen Research and Development, LLC, Spring House, Pennsylvania.
  • Gaudet F; Janssen Research and Development, LLC, Spring House, Pennsylvania.
  • Pillarisetti K; Janssen Research and Development, LLC, Spring House, Pennsylvania.
  • Zweegman S; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Adams HC; Janssen Research and Development, LLC, Spring House, Pennsylvania.
  • Mutis T; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • van de Donk NWCJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, the Netherlands. n.vandedonk@amsterdamumc.nl.
Clin Cancer Res ; 26(9): 2203-2215, 2020 05 01.
Article em En | MEDLINE | ID: mdl-31969333
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complexo CD3 / Anticorpos Biespecíficos / Antígeno de Maturação de Linfócitos B / Anticorpos Monoclonais / Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complexo CD3 / Anticorpos Biespecíficos / Antígeno de Maturação de Linfócitos B / Anticorpos Monoclonais / Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article